Orthopedic

Mike Matson, an analyst with Needham & Company, said the deal was highly favorable. Medtronic is set to acquire Medicrea for about €7.00 per share, a premium of 22% over the closing price of shares on July 14.

Canaccord Genuity's latest survey of orthopedic surgeons shows a "sharp bounce-back" in orthopedic surgery volumes, but the survey also raises concerns about sustainability, as COVID-19 rages on.

An orthopedic surgeon and an industry executive talk about the "new normal" in elective surgery, even as COVID-19 cases surge in various parts of the country.

The device is part of the Carlsbad, CA-based company’s MIS Ultra Suite of products.

Xenco's CancelleX porous titanium implant is optimized for energy absorption and bone in-growth, and designed to achieve bone-like mechanical properties.

Gov. Greg Abbott signed an executive order to pause elective surgery after the state reported more than 5,000 new cases for three consecutive days and broken COVID-19 hospitalization records for 13 days in a row.

The Chicago, IL-based firm’s employees formed a limited liability company to help close its $15 million Series B round and commercialize the xvision Spine system (XVS), an augmented reality surgical image guidance technology.

Analysts are reporting signs of recovery in procedure volumes, but getting back to normal is proving to be an uphill battle, particularly for orthopedic and spine surgeons.

The new implant was specifically designed to simplify key stages of spinal fusion surgery to help restore spinal disc height between two vertebrae.

The Carlsbad, CA said after consideration and analysis of the ongoing market effects of the COVID-19 pandemic, it is terminating the deal because of material adverse effect resulting in circumstances that are no longer conducive to the completion...